Clinitech Laboratory Share Price | Clinitech Laboratory Stock Screener
CTLLAB
Healthcare Service Provider
Track Clinitech Laboratory share price live with TickJournal's free stock screener.
Check CTLLAB yearly price range for the annual price range and momentum.
Use the Clinitech Laboratory stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Clinitech Laboratory Market Cap
₹9.20 Cr.
CTLLAB P/E Ratio (TTM)
-
Clinitech Laboratory P/B Ratio
1.04
EPS (TTM)
₹1.90
Dividend Yield
-
Debt to Equity
0.07
CTLLAB 52 Week High
-
Clinitech Laboratory 52 Week Low
-
Operating Margin
-
Profit Margin
-
CTLLAB Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹11.00
Total Equity
₹9.00
Clinitech Laboratory Share Price Chart
Screen Clinitech Laboratory share price with an interactive chart. Analyse CTLLAB price trends and volatility across different timeframes.
Clinitech Laboratory Company Profile - Fundamental Screener
Screen Clinitech Laboratory company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CTLLAB shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0QMR01015
Clinitech Laboratory Balance Sheet Screener
Screen CTLLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 11 | 6 | 6 | 4 | 3 |
| Current Assets | 7 | 3 | 2 | 1 | 2 |
| Fixed Assets | 2 | 2 | 1 | 2 | 1 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 9 | 4 | 2 | 2 | 1 |
| Share Capital | 2 | 2 | 2 | 2 | 1 |
| Reserves & Surplus | 7 | 2 | 1 | 0 | 1 |
Clinitech Laboratory Income Statement Screener - Profit & Revenue Analysis
Screen Clinitech Laboratory income statement and profit fundamentals.
Analyze CTLLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Clinitech Laboratory share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 9 | 6 | 6 | 7 | 5 |
| Expenses | 0 | 7 | 5 | 5 | 5 | 4 |
| EBITDA | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | 10.00% | 16.00% | 21.00% | 17.00% | 18.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 0 |
| EPS | 0.00 | 1.90 | 2.37 | 4.09 | 3.42 | 6.04 |
Clinitech Laboratory Cash Flow Screener - Liquidity Fundamentals
Screen CTLLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | 1 | 1 | 0 |
| Investing Activities | -1 | 1 | -1 | -2 | 1 |
| Financing Activities | 4 | 0 | 0 | 0 | -1 |
| Net Cash Flow | 2 | 0 | 1 | 0 | 0 |
Clinitech Laboratory Shareholding Pattern Screener
See Clinitech Laboratory shareholding pattern with promoter, FII, and DII holdings.
Check Clinitech Laboratory promoter holding and ownership changes for CTLLAB on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2024-Jan | 2024-Jul | 2024-Sept |
|---|---|---|---|---|---|---|
| Promoter Holding | 64.20% | 61.58% | 62.42% | 83.63% | 61.58% | 61.58% |
| FII Holding | 0.32% | 0.32% | 0.32% | 0.00% | 0.32% | 0.32% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 34.17% | 36.28% | 35.91% | 0.00% | 33.81% | 35.91% |
| Other Holding | 1.31% | 1.83% | 1.36% | 16.37% | 4.30% | 2.20% |
| Shareholder Count | 297 | 303 | 303 | 24 | 450 | 346 |
Clinitech Laboratory Share Dividend Screener - Share Yield Analysis
Check Clinitech Laboratory dividend history with payout and yield data.
View Clinitech Laboratory dividend details including ex-dates and amounts for CTLLAB stock.
Clinitech Laboratory Stock Index Membership
See which indices include Clinitech Laboratory stock.
Check CTLLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Clinitech Laboratory Market Events Screener - Corporate Actions
Get Clinitech Laboratory corporate actions including splits, bonuses, and buybacks.
Check Clinitech Laboratory stock events that may affect CTLLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -14.50% | ||
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | 0.00% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 4.76% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -1.22% |
Clinitech Laboratory Competitors Screener - Peer Comparison
Screen CTLLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 26,876 | 53.50 | 2,763 | 8.15% | 510 | 55.66 |
| Vijaya Diagnostic Centre | 12,961 | 72.87 | 814 | 16.36% | 182 | 60.54 |
| Metropolis Healthcare | 11,213 | 56.27 | 1,646 | 22.25% | 185 | 62.69 |
| Thyrocare Technologies | 7,994 | 45.59 | 829 | 18.06% | 156 | 71.28 |
| Nephrocare Health Services | 6,092 | 79.31 | 999 | 29.74% | 62 | 56.47 |
| Krsnaa Diagnostics | 1,781 | 22.68 | 743 | 16.70% | 78 | 32.60 |
| Suraksha Diagnostic | 1,539 | 51.38 | 310 | 21.30% | 34 | 51.56 |
| 3B BlackBio DX | 1,028 | 17.70 | 112 | 28.72% | 48 | 41.85 |
| Health X Platform | 999 | 33.22 | 1,171 | -18.47% | -134 | 64.03 |
| One Global Service Provider | 852 | 14.18 | 148 | 134.60% | 19 | 40.48 |
Clinitech Laboratory Company Announcements - News Screener
Screen CTLLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-24 | Board Meeting Intimation for Board Meeting For FY 2026-27 To Be Held On Thrusday May 28 2026 At 02.30 P.M Through Video Conferencing | - |
| 2026-04-27 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-25 | General Update W.R.T Memorandum Of Understanding ("MOU") | - |
| 2026-04-22 | Non-Applicability Of Reg 23 Of SEBI (LODR) Regulations 2015 W.R.T Related Party Transaction | - |
| 2026-04-15 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-04-09 | General Update Under Reg 30 Of SEBI (LODR) Regulations For Change In Market Maker | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-06 | General Update W.R.T Receipt Of Letter From Promoter Under Reg 31(4) Of SEBI (SAST) Regulations For The Year Ended March 31 2026 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-27 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-14 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-02-17 | Announcement Under Reg 30 Of SEBI (LODR)- Update W.R.T Incorporation Of Subsidiary | - |
| 2026-02-06 | Board Meeting Outcome for Outcome Of 09Th Board Meeting Held Today At Its Registered Office | - |